Release of PEGylated granulocyte-macrophage colony-stimulating factor from chitosan/glycerol films

被引:35
作者
Brown, CD
Kreilgaard, L
Nakakura, M
Caram-Lelham, N
Pettit, DK
Gombotz, WR
Hoffman, AS
机构
[1] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[2] Immunex Corp, Dept Analyt Chem & Formulat, Seattle, WA USA
关键词
chitosan; GM-CSF; poly(ethylene glycol); glycerol; FTIR;
D O I
10.1016/S0168-3659(01)00260-7
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
We have prepared a new formulation for mucosal delivery of GM-CSF or PEGylated GM-CSF based on a chitosan carrier plus added glycerol to control the rate of release of the protein. Thin dry films comprised of various weight ratios of chitosan to glycerol and containing either granulocyte-macrophage colony-stimulating factor (GM-CSF) or PEGylated GM-CSF, PEG-(GM-CSF), were prepared. The amount of GM-CSF or PEG-(GM-CSF) released from the chitosan/glycerol films was determined using size exclusion high performance liquid chromatography (HPLC-SEC). The amount of PEG-(GM-CSF) released from the films decreased with an increase in the amount of glycerol present in the film. In parallel with this, films with higher glycerol content exhibited a lower degree of equilibrium swelling when immersed in release media, pH measurements of the release media and analysis of the dried films by Fourier-transform infrared spectroscopy (FTIR) suggested that the amount of residual acetic acid in the dry films decreased as the glycerol content increased. This indicates that glycerol may act by displacing and releasing bound acetic acid from the chitosan molecules, resulting in chitosan-glycerol hydrogen bond formation as the film dries. Further, it was found that the release rate and the amount of PEG-(GM-CSF) released decreased with increasing molecular weight of the conjugated PEG. This effect was not observed with films containing physical mixtures of PEG and GM-CSF. The decrease in the fraction of PEG-(GM-CSF) released with increasing PEG molecular weight is believed to be due to the increased steric hindrance of the PEGylated protein molecule during its diffusion out of the swollen chitosan/glycerol film, (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 26 条
[1]
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[2]
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
[3]
Preparation and properties of modified chitosan films for drug release [J].
Angelova, N ;
Manolova, N ;
Rashkov, I ;
Maximova, V ;
Bogdanova, S ;
Domard, A .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 1995, 10 (04) :285-298
[4]
Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers [J].
Aspden, TJ ;
Mason, JDT ;
Jones, NS ;
Lowe, J ;
Skaugrud, O ;
Illum, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :509-513
[5]
BIOLOGICAL-ACTIVITIES OF POLYETHYLENE-GLYCOL IMMUNOGLOBULIN CONJUGATES - RESISTANCE TO ENZYMATIC DEGRADATION [J].
CUNNINGHAMRUNDLES, C ;
ZHUO, Z ;
GRIFFITH, B ;
KEENAN, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 152 (02) :177-190
[6]
DELGADO C, 1992, CRIT REV THER DRUG, V9, P249
[7]
CHITOSAN CARBOXYLIC-ACID SALTS IN SOLUTION AND IN THE SOLID-STATE [J].
DEMARGERANDRE, S ;
DOMARD, A .
CARBOHYDRATE POLYMERS, 1994, 23 (03) :211-219
[8]
DORR RT, 1994, CANC CHEMOTHERAPY HD, P829
[9]
Controlled release of endothelial cell growth factor from Chitosan-albumin microspheres for localized angiogenesis: In vitro and in vivo studies [J].
Elcin, YM ;
Dixit, V ;
Gitnick, G .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 1996, 24 (03) :257-271
[10]
GOMBOTZ WR, 2000, CONTROLLED DRUG DELI, P110